Regional Healthcare Providers and Partners

Cancer Centre Contact Us



Regional Cancer Programs were created and are funded by Cancer Care Ontario. They respond to local cancer issues. They also coordinate care across local and regional healthcare providers, and work to continually improve access to care, wait times and the quality of programs and services.

The Erie St. Clair Regional Cancer Program is responsible for the quality and delivery of cancer services for the areas of Chatham-Kent, Sarnia/Lambton and Windsor/Essex. It is a network of healthcare professionals and organizations involved in cancer prevention and care. It is overseen by a Regional Vice President of Cancer Services and is supported by staff.

It is one of 14 Regional Cancer Programs across Ontario. For each Regional Cancer Program, there is a regional cancer centre. Windsor Regional Hospital operates the regional cancer centre for Erie St. Clair.

The following links contain additional information about the Regional Cancer Program and Cancer Care Ontario:  

Erie St. Clair Regional Cancer Program Partners



Coming soon.



Clinical Trials

A clinical trial is a type of research study that helps to find new ways to diagnose, treat, manage or prevent a disease. Clinical trials test new drugs, new ways to do radiation or surgery, or any combination of these.
Clinical trials help us learn about how to make cancer treatment and cancer care better. Most of the treatments prescribed by physicians who went through the clinical trial process at some point; this is how it was determined that they would benefit patients.

In order to conduct clinical trials, investigators must satisfy a number of regulatory requirements and ensure the trial and all its components are approved by a Research Ethics Board.

At WRH, the Cancer Program has a Clinical Trials Department which facilitates meeting these regulatory requirements and also assists in running and managing Clinical Trials. We currently have 5 staff members in the department, four Study Coordinators running the trials and recruiting patients, and one Business Coordinator who manages the day to day and administrative logistics, including study contracts, budgets, training requirements and study startup.

Study Short Name Protocol Title Principal Investigator
TREATER+IGHT  Treatment of Canadian Postmenopausal Women with ER+ Advanced Breast Cancer in the Real-World Setting with Hormone Therapy ± Targeted Therapy  Dr. Swati Kulkarni
JASMINE 20130109 A randomized, Double-blind Study Evaluating the efficacy, safety and immunogenicity of ABP 798 compared with Rituximab in subjects with CD20 Positive B-Cell Non-Hodgkin Lymphoma (NHL) Dr. Caroline Hamm
PCS VI Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate  Dr. Junaid Yousuf
LUSTRE Medically-inoperative Stage I non-small cell lung cancer comparing stereotactic body radiotherapy vs conventional radiotherapy Dr. Khalid Hirmiz
BMS CA209-451   A Randomized, Multicenter, Double-Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination with Ipilimumab, or Placebo as Maintenance Therapy in Subjects with Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) after Completion of Platinum-based First Line Chemotherapy  Dr. Tarek Elfiki
BR.34  A Randomized Trial of Durvalumab (MEDI4736) and Tremelimumab + Platinum-Based Chemotherapy in Patients with Metastatic (Stage IV) Squamous or Non-Squamous Non-Small Cell Lung Cancer (NSCLC)  Dr. Swati Kulkarni
 DIV-SCLC-301 A two-part, open-label, randomized, phase II/III study of dinutuximab and irinotecan vs. irinotecan for second line treatment of subjects with relapsed or refractory small cell lung cancer  Dr. Tarek Elfiki  
MERU A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer  Dr. Amin Kay
PR.19  A Randomized Phase II Trial Evaluating High Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer  Dr. Colvin Springer  
NEPA-001 - NOT YET OPEN  A Phase IV, Real World Observational Study on the Use of Akynzeo™ (netupitant/palonosetron) for the Prevention of Nausea and Vomiting in Oncology Patients Receiving Highly Emetogenic Chemotherapy (HEC) over Multiple Cycles  Dr. Rasna Gupta  

New Patient Referral Form

In order to ensure your patient is triaged in the most efficient manner, please review the Disease Site Guidelines for required work-up scans and procedures.

It is expected that the referred patient has been informed of their diagnosis of cancer prior to their referral.

Cancer Centre clerical staff will contact new patients by telephone a few days after the referral is made to provide further information about their first appointment. This may cause undue stress for newly diagnosed patients if they are unaware of their diagnosis.

It is helpful to understand the distinction between referral types, and how New Patient Referral staff respond to each:

Standard Referral
Seen within 
2 weeks of 
Patients requiring consultation with a Medical or Radiation Oncologist for consideration of treatment options.
Urgent Referral
Seen within 
72 hours from time of referral 
Please call to discuss with the WRCP attending Oncologist
Patients who require immediate chemotherapy or radiation therapy to avoid potential oncological emergencies.
Emergency Referral
Seen within 
24 hours 
Please call to discuss with the WRCP attending Oncologist
Patients requiring immediate chemotherapy or radiation therapy for a life threatening oncological emergency.

Diagnostic Assessment Programs (DAPs)

DAPs are designed to efficiently navigate patients with a suspicion of cancer to a definitive diagnosis. DAPs available in our region include Prostate, Colorectal and Lung.

If your patient meets the required referral criteria, please complete the referral form and fax it to 519-255-8688.

DAP Referral Form

Cancer Genetics Program

This program offers genetic counseling and testing for families at risk for inherited forms of cancer.

If you think that your patient’s personal and/or family history of cancer may be genetic, please complete the referral form and fax it to 519-255-8688.

Cancer Genetics Referral Form

Aboriginal Navigator

The Aboriginal Navigator helps aboriginal patients, their families and caregivers.

The Aboriginal Navigator Can:

  • Provide your patient with support at clinic visits. 
  • Help your patient and their family communicate with Oncologists and Nurses. 
  • Arrange language and cultural translation. 
  • Help your patient find appropriate services. 
  • Connect your patient to a traditional knowledge keeper. 
If your patient would benefit from the Aboriginal Navigators services listed above, please complete the referral form and fax it to 519-255-8670.

Aboriginal Patient Referral Form

Palliative Care

Palliative care aims to improve the quality of life of patients who are diagnosed with life-limiting illnesses. This medical approach looks at each individual as a whole – physically, emotionally, psychologically, and spiritually.

Patients must be active patients, and meet all three criteria to be seen:

  • • Life expectancy of less than 1 year. 
  • • Malignant pain (if pain is an issue). 
  • • Patient must be aware of referral. 

If your patient meets the required referral criteria, please complete the referral form and fax it to: 519-255-8679.

Referral Form Coming Soon.

Hospice of Windsor Essex County

Criteria for Referral: Palliative Care Physician Consultation 

A diagnosis of life threatening illness considered palliative requiring:

*** Please indicate the appropriate request on the referral form ***

  • End of Life Care – Prognosis Three Months or Less. 
  • Malignant Pain and Symptom Management – Consult Only. 
  • Non-Malignant End of Life Care – Consult/Share Care Only. 
Please Note:
  • For all End of Life referrals, the prognosis should already have been discussed.
  • Home visits are not intended to replace Primary Care responsibilities.
  • This program does not accept referrals for Chronic Non-Malignant Pain.
  • For Urgent Referrals: Call to speak to the Palliative Care Coordinator at Ext. 2254. Referrals are triaged at the time of receipt. Urgent faxes will not be accepted without telephone contact. 
If your patient meets the required referral criteria, please complete the referral form and send it to:

C/O The Hospice of Windsor Essex County Inc. 
6038 Empress Street, Windsor, Ontario N8T 1B5
Fax: 519-974-7672
Phone: 519-974-7100

Doctor's Referral Form to Palliative Medicine Physician Program

Cancer Care Ontario Resources


Diagnostic pathways 

Diagnosis and Treatment:

Pathways are a quality improvement tool for the Ontario cancer system. Pathways are flowcharts that show a high-level overview of the care a cancer patient in Ontario should receive.

The following pathways have been developed by Cancer Care Ontario to guide cancer treatment in the province:

Click here to learn more about Disease Pathway Maps - Healthcare Provider Q&A

Cancer Care Ontario Disease Pathway Management


MCCs are regularly scheduled meetings where healthcare providers discuss the diagnosis and treatment of individual cancer patients. Participants represent medical oncology, radiation oncology, surgical oncology, pathology, diagnostic radiology and nursing.

To submit a patient for review at an MCC, please complete the MCC Submission Form and submit to or fax to 519-255-8687.

Windsor Regional Hospital MCC Calendar

Breast Reconstruction Booklet

Learn more about breast reconstruction options in this Breast Reconstruction Resource.

Survivorship Resources

Continuing Medical Education Opportunity

Cancer Survivorship 101: Clinical Pearls for Primary Care is a 1.5-hour accredited CME for Primary Care Providers (PCPs) that discusses the role of PCPs in the follow-up care of cancer survivors and what resources are available. 

If you are interested in this CME, please call 519-254-5577 x58620.

Survivorship - Information on Common Concerns

The Canadian Cancer Society highlights some common concerns that cancer survivors may face when thinking about the future:


Your input assists our Patient and Family Advisory Council in making lasting impact improvements for patients with cancer and their caregivers across the Erie St. Clair Region in the areas of prevention, screening, diagnosis, treatment, survivorship, palliative and end-of-life care.

Council membership includes patients, family members and caregivers from the Chatham-Kent, Sarnia/Lambton and Windsor/Essex area. Membership also includes cancer program leadership and staff.

The Patient & Family Advisory Council meets four times per year. To acknowledge the significant partnership between the cancer program and patients/family/caregivers, meetings and outcomes are guided by membership and are led by a Program Chair and Patient Chair.

For more information, please see the documents below, or contact our Call Centre at 519-253-5253.



The Erie St. Clair Regional Cancer Program Clinical Leads.

Lead Title
Dr. Youssef Almalki Cancer Imaging Lead, Breast Imaging Lead
Dr. Elizabeth Haddad
Colorectal Screening / GI Endoscopy Lead
Dr. Tamara Siddall Primary Care Lead (Day 1 – Prevention, Screening, Diagnosis)
Dr. John Mathews Quality Lead, Systemic Treatment
Ms. Sarah Mushtaq Patient Education Lead
Dr. Anat Ravid Surgical Oncology Lead
Dr. Joslyn Warwaruk Primary Care Lead (Day 2 – Survivorship, Palliative Care, and End-of-Life)
Ms. Priya Philip Psychosocial Oncology Lead
Dr. Ken Schneider Radiation Clinical Lead
Dr. Mohammad Alomari Pathology Lead
Dr. Mark Tomen Aboriginal Cancer Lead
Dr. Neerja Sharma Regional Colposcopy / Cervical Cancer Screening Lead
Ms. Priya Philip Co-Patient and Family Engagement and Experience Lead
Ms. Melissa Lot Oncology Nursing Lead
Dr. Glen Maddison Co-Regional Multidisciplinary Physician Lead, Erie St. Clair Regional Hospice Palliative Care Network
Ms. Janet Elder Co-Regional Multidisciplinary Clinical Lead, Erie St. Clair Regional Hospice Palliative Care Network

Cancer Centre Contact Information.